Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PLD2 inhibitors(phospholipase D2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H29N5O2 |
InChIKeyVBJYNYMKFQGJCH-UHFFFAOYSA-N |
CAS Registry1638957-17-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Preclinical | US | 10 Sep 2014 |